Unlike its counterpart with DAC (Drug Affinity Complex), this version lacks the DAC component, resulting in a shorter half-life and reduced duration of action
What Does the Scientific Evidence Say Efficacy & Safety (2025 Overview) When we examine the medical literature (clinical studies, reviews, regulatory data), a clearer and more cautionary picture emerges: A 2015 review of all published studies up to that time concluded that: there is no robust evidence supporting IV glutathione for skin lightening
Two defense-related genes, encoding a GST and a cytochrome P450, were regulated downstream of WRKY45, but were not regulated by NH1, suggesting independence of the WRKY45 and NH1 pathways (Shimono et al., 2007)
Diabetic Retinopathy Complications in Patients with Type 2 Diabetes In a 2-year trial with semaglutide 0.5 mg and 1 mg once-weekly injection in adult patients with type 2 diabetes and high CV risk, diabetic retinopathy complications (which was a 4-component adjudicated endpoint) occurred in patients treated with semaglutide injection (3%) compared to placebo (1.8%)
References Obesity and overweight